Zevra Therapeutics: Promising Launch Prospects and Strategic Initiatives Drive Buy Rating
Analyst Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Zevra Therapeutics (ZVRA – Research Report) and increased the ...
JMP Securities Remains a Buy on Similarweb (SMWB)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...
JPMorgan Asset Management’s Ward Sees Fed on Hold in 2025
The Federal Reserve is likely to pause its interest-rate cuts after December to assess the economic impact of policies under ...
Yahoo Finance12h
Q3 2024 Taysha Gene Therapies Inc Earnings Call
Taysha undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by applicable ...
JD Supra10h
SEC Will Prioritize AI, Cybersecurity, and Crypto in its 2025 Examination Priorities
On October 21, 2024, the US Securities and Exchange Commission ("SEC") Division of Examinations ("Examination Division") announced its ...
Indiatimes11h
Inventure Grwth - Inventure Growth & Securities Share Price
Inventure Growth & Securities Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 224.70 Crore) operating in Financial Services sector. Inventure Growth & Securities ...
Indiatimes9h
UTI AMC - UTI Asset Management Company Share Price
UTI Asset Management Company Ltd. key Products/Revenue Segments include Sale of services, Income From Sale Of Share & Securities, Interest and Rental Income for the year ending 31-Mar-2024.For the ...